Ingrid Atteryd Heiman has decided to leave Herantis Pharma's Board of Directors
Herantis Pharma Plc Company release, 30 October 2020 at 6 p.m. Eastern European Time Herantis Pharma Plc (“Herantis”) announces Ingrid Heiman's decision to step down from her role in Herantis' Board of Directors effective immediately. Ingrid Heiman's tenure in Herantis' Board of Directors commenced in the extraordinary general meeting held in the spring of 2019. “The Board and I wish to thank Ingrid for her work and commitment in the Board of Directors. With her participation, Herantis has pushed forward our mission of breaking the boundaries of standard therapeutic approaches with